News

Article

Alvotech, Prestige Biopharma Form New Manufacturing Partnership

Alvotech and Prestige Biopharma, have announced the formation of a new contract manufacturing partnership for the commercial production of a biosimilar.

Biopharmaceutical companies, Alvotech and Prestige Biopharma, have announced in an Aug. 27, 2019 press release the formation of a new contract manufacturing partnership for the commercial production of a biosimilar.

As per the agreement, Alvotech Contract Services will assume the responsibilities of commercially producing one of Prestige Biopharma’s biosimilar candidates. Production of the biosimilar will take place at Alvotech’s new biosimilar facility based in Reykjavik, Iceland. Scale up and process validation of the manufacturing process will be performed at the Reykjavik facility also.

“The partnership with Prestige BioPharma marks an important milestone for our company as we work towards expanding our contract manufacturing business,” said Mark Levick, Alvotech’s CEO, in the press release. “We are pleased to be trusted with the responsibility of delivering high quality manufacturing services to Prestige Biopharma and look forward to further collaboration in the future. We pride ourselves on delivering highest quality commercial production from one of the best biopharma facilities in the world.”

Both companies will start technology transfer immediately, which will be followed by commercial manufacture of the compound.

Source: Alvotech

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content